• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

851983-85-2 (TOK-001)

1

Identification

TOK-001 TOK-001
Name TOK-001
Formula C26H32N2O
MW 388.55
CAS No. 851983-85-2
EINECS
Smiles C[[email protected]@]12C(N3C=NC4=CC=CC=C34)=CC[[email protected]]1([[email protected]@]5(CC=C6[[email protected]@](C)([[email protected]]5(CC2)[H])CC[[email protected]@H](C6)O)[H])[H]
Synonyms VN/124-1; Galeterone; VN 124;TOK001;TOK 001; (3S,8R,9S,10R,13S,14S)-17-(1H-benzo[d]imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChI InChI=1S/C26H32N2O/c1-25-13-11-18(29)15-17(25)7-8-19-20-9-10-24(26(20,2)14-12-21(19)25)28-16-27-22-5-3-4-6-23(22)28/h3-7,10,16,18-21,29H,8-9,11-15H2,1-2H3/t18-,19-,20-,21-,25-,26-/m0/s1
2

Introduction

TOK-001 (VN/124-1; Galeterone) is a multifunctional antiandrogen and CYP17 inhibitor(IC50=47 nM) in castration resistant prostate cancer (CRPC). IC50 value: 47 nM Target: CYP17 TOK-001 and abiraterone reduced AR protein and mRNA expression, and antagonized AR-dependent promoter activation induced by androgen.

Background Information

TOK-001 (VN/124-1; Galeterone) is a multifunctional antiandrogen and CYP17 inhibitor(IC50=47 nM) in castration resistant prostate cancer (CRPC). IC50 value: 47 nM Target: CYP17 TOK-001 and abiraterone reduced AR protein and mRNA expression, and antagonized AR-dependent promoter activation induced by androgen. TOK-001, but not abiraterone, is an effective apparent competitor of the radioligand [(3)H]R1881 for binding to the wild type and various mutant AR (W741C, W741L) proteins. TOK-001 is a consistently superior inhibitor than abiraterone of R1881-induced transcriptional activity of both wild type and mutant AR. in vivo: ......by MedChemexpress Co., Ltd.
Shelf life: >2 years if stored properly Drug formulation: ......by MedKoo Biosciences, Inc.
Galeterone is a selective CYP17 inhibitor and androgen receptor (AR) antagonist with IC50 of 300 nM and 384 nM, respectively, and is a potent inhibitor of human prostate tumor growth. Phase 2. ......by Selleck Chemicals LLC
Galeterone is a selective CYP17 inhibitor and androgen receptor (AR) antagonist with IC50 of 300 nM and 384 nM, respectively, and is a potent inhibitor of human prostate tumor growth. Phase 2. ......by Target Molecule Corp.
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

Animal Models Male severe combined immunodeficient (SCID) mice inoculated subcutaneously (s.c.) with LAPC4 cells
Dosage 50 mg/kg
Formulation Prepared at 17.2 mg/mL in a 0.3% solution of hydroxypropyl cellulose in saline
Administration Injection s.c. twice daily
Source Selleck Chemicals LLC
4

Physical and Chemical Properties

Appearance:White to off-white solid EBNumber:EB000028832

Storage condition

Solubility

DMSO by MedChemexpress Co., Ltd.
(25°C) * In vitro DMSO 24 mg/mL (61.76 mM); Ethanol40 mg/mL warming (102.94 mM); Water<1 mg/mL (<1 mM); In vivo 0.5% hydroxyethyl cellulose30 mg/mL by Selleck Chemicals LLC
5

Mechanism and Indication

6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
TOK-001 Tokai Pharmaceuticals Inc Hormone refractory prostate cancer 2012/12/31 2014/9/30 Phase 2 Clinical
TOK-001 Tokai Pharmaceuticals Inc Hormone refractory prostate cancer 2009/10/31 2012/8/31 Phase 1 Clinical
TOK-001 - Phase 3
7

Safety Data of TOK-001

8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
CHEMSCENE, LLC 10mg/USD180(In stock);50mg/USD550(In stock) USA
MedChemexpress Co., Ltd. 5mg/USD100(In stock);10mg/USD180(In stock);50mg/USD550(In stock);100mg/USD850(In stock) USA
MedKoo Biosciences, Inc. USA
Pure Chemistry Scientific Inc. 5mg/USDnull(In stock) USA
Selleck Chemicals LLC 5mg/USD170(In stock);10mM/1mLIn DMSO/USD260(In stock);25mg/USD470(In stock);50mg/USD670(In stock);200mg/USD1670(In stock) USA
Shanghai Haoyuan Chemexpress Co., Ltd. 10mg/USD240(In stock);50mg/USD600(In stock) China
Target Molecule Corp. 5mg/USD97();10mg/USD171();50mg/USD528() USA
10

Related Products

Other Forms of 851983-85-2

Name CAS No Formula MW

Recommended Compounds in Cytochrome P450

Name CAS No Formula MW
Dafadine-A 1065506-69-5 C23H25N3O3 391.46
VT-464 (racemate) 1375603-36-3 C18H17F4N3O3 399.34
VT-464 1610537-15-9 C18H17F4N3O3 399.34
Isosilybin 72581-71-6 C25H22O10 482.44
Memantine (hydrochloride) 41100-52-1 C12H22ClN 215.76
Clarithromycin 81103-11-9 C38H69NO13 747.95
(+)-Ketoconazole 142128-59-4 C26H28Cl2N4O4 531.43
Ketoconazole 65277-42-1 C26H28Cl2N4O4 531.43
Galangin 548-83-4
Bergapten 484-20-8 C12H8O4 216.19
Naringin 10236-47-2 C27H32O14 580.53
Diosmetin 520-34-3 C16H12O6 300.26
Fenofibrate 49562-28-9 C20H21ClO4 360.83
4-hydroxy-7H-furo[3,2-g]chromen-7-one 486-60-2 C11H6O4 202.16
(R)-Talarozole 870093-23-5 C21H23N5S 377.51
Choline Fenofibrate 856676-23-8 C22H28ClNO5 421.91
Talarozole 201410-53-9 C21H23N5S 377.51
BAL 4815 241479-67-4 C22H17F2N5OS 437.47
Cobicistat 1004316-88-4 C40H53N7O5S2 776.02
Methoxsalen 298-81-7 C12H8O4 216.19

Recommended Compounds in Same Indication

Name CAS No Formula MW
TAK-700 (R-form) 752243-39-3 C18H17N3O2 307.35
Olaparib 763113-22-0 C24H23FN4O3 434.46
KX2-391 897016-82-9 C26H29N3O3 431.53
Bicalutamide 90357-06-5 C18H14F4N2O4S 430.37
Enzalutamide 915087-33-1 C21H16F4N4O2S 464.44
Linsitinib 867160-71-2 C26H23N5O 421.49
Fenretinide 65646-68-6 C26H33NO2 391.55
Retaspimycin 857402-23-4 C31H45N3O8 587.7
Retaspimycin (Hydrochloride) 857402-63-2 C31H46ClN3O8 624.17
(S)-N-(3-([4,5'-bipyrimidin]-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide 859212-16-1 C30H31F3N8O 576.62
AT13387 912999-49-6 C24H31N3O3 409.52
Tasquinimod 254964-60-8 C20H17F3N2O4 406.36
Orteronel 566939-85-3 C18H17N3O2 307.35
TAK-700 426219-18-3 C18H17N3O2 307.35
TAK-700 (salt) 426219-53-6 C28H28N4O7 532.54
Cabozantinib 849217-68-1 C28H24FN3O5 501.51
Odanacatib 603139-19-1 C25H27F4N3O3S 525.56
Zibotentan 186497-07-4 C19H16N6O4S 424.43
Danusertib 827318-97-8 C26H30N6O3 474.55
Atrasentan 173937-91-2 C29H38N2O6 510.62
11

Route of Synthesis

12

References

13

More Information

TOK-001

Tags: buy 851983-85-2 IC50 | 851983-85-2 price | 851983-85-2 cost | 851983-85-2 solubility | 851983-85-2 purchase | 851983-85-2 manufacturer | 851983-85-2 research buy | 851983-85-2 order | 851983-85-2 MSDS | 851983-85-2 chemical structure | 851983-85-2 Storage condition | 851983-85-2 molecular weight | 851983-85-2 mw | 851983-85-2 datasheet | 851983-85-2 supplier | 851983-85-2 cell line | 851983-85-2 NMR | 851983-85-2 MS | 851983-85-2 IR | 851983-85-2 solubility | 851983-85-2 Safe information | 851983-85-2 Qc and Spectral Information | 851983-85-2 Clinical Information | 851983-85-2 Clinical Trial | 851983-85-2 Route of Synthesis | 851983-85-2 storage condition | 851983-85-2 diseases and conditions | 851983-85-2 flash point | 851983-85-2 boiling point | 851983-85-2 melting point | 851983-85-2 storage condition | 851983-85-2 brand